Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. KEYS
2. KLAR
3. PANW
4. MRNA
5. HD
6. DVLT
7. LOW
8. MRK
9. PGR
10. EPM

Go back to Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
(NASDAQ: KNSA) Delayed: 80.75 +1.26 (1.59%)
Previous Close $79.49    52 Week High $ 
Open $80.50    52 Week Low $ 
Day High $81.57    P/E N/A 
Day Low $79.27    EPS $ 
Volume 262,432